Cargando…
Role of complement in myasthenia gravis
Myasthenia gravis is a prototypic neuroimmune disorder with autoantibodies targeting the acetylcholine receptor complex at the neuromuscular junction. Patients present with mainly ocular muscle weakness and tend to have a generalized muscle weakness later in the clinical course. The weakness can be...
Autores principales: | San, Pyae Phyo, Jacob, Saiju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585143/ https://www.ncbi.nlm.nih.gov/pubmed/37869140 http://dx.doi.org/10.3389/fneur.2023.1277596 |
Ejemplares similares
-
Novel Immunotherapies for Myasthenia Gravis
por: Nair, Sruthi S, et al.
Publicado: (2023) -
Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021) -
A Case of Pembrolizumab-Induced Myasthenia Gravis
por: Kosick, Thomas I, et al.
Publicado: (2023) -
Rituximab treatment in myasthenia gravis
por: Vesperinas-Castro, Ana, et al.
Publicado: (2023) -
Novel Treatments in Myasthenia Gravis
por: Menon, Deepak, et al.
Publicado: (2020)